MarketInOut Stock Screener Log In | Sign Up

Berry Genomics Co Ltd A

SZSE • Healthcare • Diagnostics & Research • Quote as of 10/28/2026 13:35
Berry Genomics Co Ltd A stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeSZSE
Market Capitalization4,136.2 mln
Float314 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.94
Likely reliable

Relative Strength

33 / 100
Underperforming

Debt / Equity

0.18
Very low leverage

Pre-Tax Margin

-22%
Deeply loss-making

ROE

-13.74
Negative

Business Description

Founded in Beijing in 2010, Berry Genomics develops and sells genetic testing products and services for medical and research use across China and several international markets. Its offerings range from prenatal DNA testing and cancer genetic screening to advanced gene sequencing equipment and laboratory tools. The company also handles large-scale data analysis and serves a broad client base that includes hospitals, universities, and research organizations across Asia, the Middle East, and Australia.

Key Fundamentals

EPS-0.60
ROE-13.74
RPS2.63
ROIC-11.31
ROA-9.15
Interest Cover-26.68
EBITDA, mln-118
EV / EBITDA-33.07
EV / EBIT-20.07
Revenue, mln929
EV / Revenue4.19

Quote Details

Last 9.77
Change 0.57 (6.2%)
Open 9.21
Volume 26,491,800
Turnover 258,824,896
Average Volume 52,707,516

Financial Ratios

Pre-Tax Profit Margin-22
Leverage Ratio1.52
Current Ratio2.12
Price / Book2.64
Price / Tangible Book2.81
Debt / Equity0.18
Price / Sales4.13

Financial Strength

Altman Z-Score3.6
Piotroski F-Score 3 / 9
Beneish M-Score-2.94
Shiller PE Ratio109

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.03% 11 / 100   
1 Month 4.16% 93 / 100   
2 Months 17.29% 94 / 100   
6 Months -1.81% 86 / 100   
1 Year -23.31% 34 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog